JEANETTE FORONDA: Open Payments
NPI 1013033778 · FREDERICK, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$831 in 36 payments from 15 companies in 2025. Trend: 2023 $1,743 · 2024 $1,783 · 2025 $831
Food & beverage: $805Education: $26
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 6 | $110 |
| ABBVIE INC. | 5 | $109 |
| Janssen Pharmaceuticals, Inc | 3 | $78 |
| Merck Sharp & Dohme LLC | 3 | $76 |
| PROGENICS PHARMACEUTICALS, INC. | 3 | $71 |
| Astellas Pharma US Inc | 3 | $70 |
| Novartis Pharmaceuticals Corporation | 2 | $61 |
| Antares Pharma, Inc. | 2 | $52 |
| UROGEN PHARMA, INC. | 2 | $46 |
| DENTSPLY IH AB | 2 | $38 |
Products named: ERLEADA, BOTOX, PYLARIFY, Xtandi, PLUVICTO, GEMTESA, ORGOVYX, XYOSTED.
Industry payments across MD — which companies pay providers there.
